Talebian, H.; Ait-Mohand, S.; Ignatius Arokia Doss, P.M.; Sanche, L.; Guérin, B.
Development and In Vitro Evaluation of [64Cu]Cu-NOTA-TP-PSMA, a Novel Radiotheranostic Agent Against Prostate Cancer. Int. J. Mol. Sci. 2025, 26, 11651.
https://doi.org/10.3390/ijms262311651
AMA Style
Talebian H, Ait-Mohand S, Ignatius Arokia Doss PM, Sanche L, Guérin B.
Development and In Vitro Evaluation of [64Cu]Cu-NOTA-TP-PSMA, a Novel Radiotheranostic Agent Against Prostate Cancer. International Journal of Molecular Sciences. 2025; 26(23):11651.
https://doi.org/10.3390/ijms262311651
Chicago/Turabian Style
Talebian, Hoda, Samia Ait-Mohand, Prenitha Mercy Ignatius Arokia Doss, Léon Sanche, and Brigitte Guérin.
2025. "Development and In Vitro Evaluation of [64Cu]Cu-NOTA-TP-PSMA, a Novel Radiotheranostic Agent Against Prostate Cancer" International Journal of Molecular Sciences 26, no. 23: 11651.
https://doi.org/10.3390/ijms262311651
APA Style
Talebian, H., Ait-Mohand, S., Ignatius Arokia Doss, P. M., Sanche, L., & Guérin, B.
(2025). Development and In Vitro Evaluation of [64Cu]Cu-NOTA-TP-PSMA, a Novel Radiotheranostic Agent Against Prostate Cancer. International Journal of Molecular Sciences, 26(23), 11651.
https://doi.org/10.3390/ijms262311651